Pages that link to "Q40548802"

The following pages link to Current perspectives of 14 C-isotope measurement in biomedical accelerator mass spectrometry (Q40548802):

Displaying 28 items.

• The use of accelerator mass spectrometry to obtain early human ADME/PK data (Q31055937) (← links)
• Accelerator mass spectrometry-enabled studies: current status and future prospects (Q33819361) (← links)
• The use of isotopes in the determination of absolute bioavailability of drugs in humans (Q34550493) (← links)
• Use of microdosing and accelerator mass spectrometry to evaluate the pharmacokinetic linearity of a novel tricyclic GyrB/ParE inhibitor in rats (Q34596727) (← links)
• Quantifying exploratory low dose compounds in humans with AMS (Q34708648) (← links)
• Towards biomarker-dependent individualized chemotherapy: exploring cell-specific differences in oxaliplatin-DNA adduct distribution using accelerator mass spectrometry (Q35041359) (← links)
• Phase 0 Workshop at the 20th EORTC-NCI-AACR Symposium, Geneva. (Q35602195) (← links)
• Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometry. (Q35884220) (← links)
• Measurement of 7,8-dihydro-8-oxo-2'-deoxyguanosine metabolism in MCF-7 cells at low concentrations using accelerator mass spectrometry (Q36090105) (← links)
• Improved early clinical development through human microdosing studies (Q36182266) (← links)
• Mass balance studies, with a focus on anticancer drugs. (Q36375326) (← links)
• Determining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry (Q36402145) (← links)
• Pharmacokinetics and tolerability of SRT2104, a first‐in‐class small molecule activator of SIRT1, after single and repeated oral administration in man (Q36562488) (← links)
• Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations (Q36868478) (← links)
• Metabolism and Disposition of [14C]BMS-690514, an ErbB/Vascular Endothelial Growth Factor Receptor Inhibitor, after Oral Administration to Humans (Q39674191) (← links)
• Precision and Accuracy in the Quantitative Analysis of Biological Samples by Accelerator Mass Spectrometry: Application in Microdose Absolute Bioavailability Studies (Q39744403) (← links)
• The phase 0 microdosing concept (Q41942832) (← links)
• Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS. (Q43067629) (← links)
• Analytical Strategies for Assessment of Human Metabolites in Preclinical Safety Testing (Q45893577) (← links)
• The application of accelerator mass spectrometry to absolute bioavailability studies in humans: simultaneous administration of an intravenous microdose of 14C-nelfinavir mesylate solution and oral nelfinavir to healthy volunteers (Q46711334) (← links)
• Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers (Q50480530) (← links)
• Selected scientific topics of the 11th International Isotope Symposium on the Synthesis and Applications of Isotopes and Isotopically Labeled Compounds. (Q53099174) (← links)
• Pharmacokinetic analysis of 14C-ursodiol in newborn infants using accelerator mass spectrometry (Q57150351) (← links)
• High-performance liquid chromatography coupled to inductively coupled plasma – Mass spectrometry (HPLC-ICP-MS) for quantitative metabolite profiling of non-metal drugs (Q59795548) (← links)
• Microdosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1), and Interaction (Grapefruit Juice) Profiles of Celiprolol Following the Oral Microdose and Therapeutic Dose (Q84142690) (← links)
• A microdose study of ¹⁴C-AR-709 in healthy men: pharmacokinetics, absolute bioavailability and concentrations in key compartments of the lung (Q86903943) (← links)
• Pharmacokinetics, Excretion, and Mass Balance of [14 C]-Batefenterol Following a Single Microtracer Intravenous Dose (Concomitant to an Inhaled Dose) or Oral Dose of Batefenterol in Healthy Men (Q91535257) (← links)
• Estimation of dietary 14C dose coefficient using 13C-labelled compound administration analysis (Q95328509) (← links)